At Televero Behavioral Health, we measure regularly
Glucagon-like peptide 1 receptor agonist (GLP1RA) exposure and outcomes in type 2 diabetes: a systematic review of population-based observational studies
These drawbacks may include common side effects, serious health risks, and the financial impact of treatment
Phase 2 body composition substudy data using DEXA scans showed that retatrutide participants lost predominantly fat mass, with a favorable fat-to-lean mass loss ratio
Marco ML, Sanders ME, Gnzle M, Arrieta MC, Cotter PD, De Vuyst L et al (2021) The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods
Implications for Obesity Treatment Policy Tirzepatide appears to be a cost-effective option with favorable modeled clinical outcomes compared to semaglutide for managing obesity and overweight in the U.S